GLP-1

Latest News and Resources

Podcast

Hybrid Synthesis is Redefining Peptide Manufacturing

26 March 2026

Content

FDA’s GLP-1 Crackdown: Regulators Are Turning Up the Heat on Manufacturing Quality

6 March 2026

Expert Insight

Novo Nordisk CEO: We Were ‘Cursed as a Leader’ as Lilly Closes GLP-1 Gap

19 January 2026

Podcast

Simtra BioPharma Solutions CEO Franco Negron on Building Supply Chain Resilience Through Geographic Redundancy

12 January 2026

Manufacturing News

Novo Nordisk wins FDA approval for oral Wegovy, launching first GLP-1 pill for obesity

23 December 2025

Podcast

CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities

4 December 2025

Manufacturing News

Novo Nordisk, Pfizer Bidding War for Metsera Escalates to $10 Billion as FTC Raises Concerns

6 November 2025

Podcast

Pharma Trends: A Commercial Perspective on Oncology, GLP-1 Expansion, and AI-Accelerated Development

30 October 2025

Expert Insight

Patient Access Barriers Drive GLP-1 Development Strategies

29 October 2025

Podcast

GLP-1s and the Unintended Consequences of the $100 Billion Market

7 November 2024